Ozempic is one of the most important new medications in a generation. The driving force behind it is the Danish pharmaceutical company Novo Nordisk, which has been invested in GLP-1 research since the early 1990s. The leading scientist in this domain, a self-described "nerd," who grew up on a farm in Denmark and has no interest in the limelight. Lotte Knudse ... Show More
Jul 20
Katie Ledecky: The Call Of The Water
She sent shockwaves through the world of competitive swimming, when she won a gold medal at the 2012 Olympics, beating out the favorites by a wide margin. She was 15 years old. Katie Ledecky is now training for her fifth Olympics, and is indisputably the greatest female swimmer o ... Show More
53m 20s
Apr 2026
Cindy Sherman: Illusions of Identity
Cindy Sherman, one of the world's most renowned contemporary art photographers, started posing for her own photos in the 1970's, long before the advent of selfies. But she says her images are not self-portraits. Instead, she uses sets, costumes and makeup to create an elaborate a ... Show More
42m 14s
Mar 2024
The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ... Show More
58m 12s
Jun 2024
Denmark and the Novo Nordisk effect
<p>In the first of a two-part series, in collaboration with The Food Chain, we look at the impact of the success of weight-loss drug manufacturer Novo Nordisk on the small country of Denmark. </p><p>The Scandinavian nation is where the company is based, and with a population of l ... Show More
17m 29s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s